Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients
Clinical trial NCT02987829 · COMPLETED
Trial details
- NCT number
- NCT02987829
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-23
- Primary completion
- 2019-10-06
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.